Nostopeptolide A2
| Internal ID | d00f661f-6dd9-4467-8ee2-5980399df384 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | (2S)-N-[(3S,7S,13S,16S,22S,27S,30S,32S)-16-(2-amino-2-oxoethyl)-13-[(4-hydroxyphenyl)methyl]-32-methyl-22,27-bis(2-methylpropyl)-2,6,12,15,18,21,24,26,29-nonaoxo-5-oxa-1,11,14,17,20,23,28-heptazatricyclo[28.3.0.07,11]tritriacontan-3-yl]-2-(butanoylamino)-3-methylbutanamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C52H78N10O14/c1-9-11-42(66)60-45(29(6)7)49(72)59-37-26-76-52(75)38-12-10-17-61(38)50(73)36(21-31-13-15-32(63)16-14-31)58-47(70)35(22-41(53)65)56-44(68)24-54-46(69)34(19-28(4)5)55-43(67)23-40(64)33(18-27(2)3)57-48(71)39-20-30(8)25-62(39)51(37)74/h13-16,27-30,33-39,45,63H,9-12,17-26H2,1-8H3,(H2,53,65)(H,54,69)(H,55,67)(H,56,68)(H,57,71)(H,58,70)(H,59,72)(H,60,66)/t30-,33-,34-,35-,36-,37-,38-,39-,45-/m0/s1 |
| InChI Key | UEVIIAJOLZZKQH-PFARYBADSA-N |
| Popularity | 4 references in papers |
| Molecular Formula | C52H78N10O14 |
| Molecular Weight | 1067.20 g/mol |
| Exact Mass | 1066.56989720 g/mol |
| Topological Polar Surface Area (TPSA) | 351.00 Ų |
| XlogP | 2.00 |
| Atomic LogP (AlogP) | -0.87 |
| H-Bond Acceptor | 14 |
| H-Bond Donor | 9 |
| Rotatable Bonds | 14 |
| (2S)-N-[(3S,7S,13S,16S,22S,27S,30S,32S)-16-(2-amino-2-oxoethyl)-13-[(4-hydroxyphenyl)methyl]-32-methyl-22,27-bis(2-methylpropyl)-2,6,12,15,18,21,24,26,29-nonaoxo-5-oxa-1,11,14,17,20,23,28-heptazatricyclo[28.3.0.07,11]tritriacontan-3-yl]-2-(butanoylamino)-3-methylbutanamide |
| (2S)-N-((3S,7S,13S,16S,22S,27S,30S,32S)-16-(2-amino-2-oxoethyl)-13-((4-hydroxyphenyl)methyl)-32-methyl-22,27-bis(2-methylpropyl)-2,6,12,15,18,21,24,26,29-nonaoxo-5-oxa-1,11,14,17,20,23,28-heptazatricyclo(28.3.0.07,11)tritriacontan-3-yl)-2-(butanoylamino)-3-methylbutanamide |
| RefChem:166772 |
| SCHEMBL17866972 |
| CHEBI:80032 |
| Q27149179 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7454 | 74.54% |
| Caco-2 | - | 0.8621 | 86.21% |
| Blood Brain Barrier | - | 0.9500 | 95.00% |
| Human oral bioavailability | - | 0.6857 | 68.57% |
| Subcellular localzation | Lysosomes | 0.4863 | 48.63% |
| OATP2B1 inhibitior | - | 0.7132 | 71.32% |
| OATP1B1 inhibitior | + | 0.8273 | 82.73% |
| OATP1B3 inhibitior | + | 0.9378 | 93.78% |
| MATE1 inhibitior | - | 0.8800 | 88.00% |
| OCT2 inhibitior | - | 0.9000 | 90.00% |
| BSEP inhibitior | + | 0.8629 | 86.29% |
| P-glycoprotein inhibitior | + | 0.7498 | 74.98% |
| P-glycoprotein substrate | + | 0.9202 | 92.02% |
| CYP3A4 substrate | + | 0.7327 | 73.27% |
| CYP2C9 substrate | + | 0.5868 | 58.68% |
| CYP2D6 substrate | - | 0.8193 | 81.93% |
| CYP3A4 inhibition | - | 0.9102 | 91.02% |
| CYP2C9 inhibition | - | 0.9498 | 94.98% |
| CYP2C19 inhibition | - | 0.9234 | 92.34% |
| CYP2D6 inhibition | - | 0.8931 | 89.31% |
| CYP1A2 inhibition | - | 0.9498 | 94.98% |
| CYP2C8 inhibition | + | 0.7764 | 77.64% |
| CYP inhibitory promiscuity | - | 0.9681 | 96.81% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8400 | 84.00% |
| Carcinogenicity (trinary) | Non-required | 0.6174 | 61.74% |
| Eye corrosion | - | 0.9882 | 98.82% |
| Eye irritation | - | 0.9001 | 90.01% |
| Skin irritation | - | 0.7824 | 78.24% |
| Skin corrosion | - | 0.9267 | 92.67% |
| Ames mutagenesis | - | 0.6500 | 65.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3968 | 39.68% |
| Micronuclear | + | 0.8900 | 89.00% |
| Hepatotoxicity | - | 0.5250 | 52.50% |
| skin sensitisation | - | 0.8723 | 87.23% |
| Respiratory toxicity | + | 0.8000 | 80.00% |
| Reproductive toxicity | + | 0.9556 | 95.56% |
| Mitochondrial toxicity | + | 0.9000 | 90.00% |
| Nephrotoxicity | + | 0.5111 | 51.11% |
| Acute Oral Toxicity (c) | III | 0.4550 | 45.50% |
| Estrogen receptor binding | + | 0.8173 | 81.73% |
| Androgen receptor binding | + | 0.7158 | 71.58% |
| Thyroid receptor binding | + | 0.5659 | 56.59% |
| Glucocorticoid receptor binding | + | 0.5817 | 58.17% |
| Aromatase binding | + | 0.6828 | 68.28% |
| PPAR gamma | + | 0.7995 | 79.95% |
| Honey bee toxicity | - | 0.7111 | 71.11% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.5000 | 50.00% |
| Fish aquatic toxicity | + | 0.7820 | 78.20% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.95% | 98.95% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 99.21% | 94.45% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.87% | 97.25% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.44% | 96.09% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 97.20% | 90.08% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 96.20% | 82.38% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 95.91% | 95.00% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 95.65% | 93.00% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 95.41% | 94.66% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 95.33% | 83.82% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.32% | 91.11% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 94.90% | 97.09% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 94.89% | 85.14% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 94.80% | 96.11% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 93.89% | 95.89% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.54% | 99.17% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 92.29% | 97.64% |
| CHEMBL4481 | P35228 | Nitric oxide synthase, inducible | 92.27% | 94.80% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 92.24% | 90.93% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 92.08% | 96.61% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 92.06% | 97.14% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 92.01% | 93.10% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 91.74% | 90.71% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 90.59% | 97.23% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 89.78% | 96.90% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 89.76% | 95.50% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 89.06% | 96.31% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 88.80% | 83.14% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 88.52% | 100.00% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 86.92% | 98.59% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 86.79% | 94.00% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 86.79% | 96.33% |
| CHEMBL6175 | Q9H3R0 | Lysine-specific demethylase 4C | 86.71% | 96.69% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 86.63% | 93.56% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 85.67% | 92.97% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 85.67% | 85.00% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 85.51% | 89.00% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 83.90% | 100.00% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 83.23% | 89.50% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 83.03% | 82.69% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 82.83% | 95.56% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 82.68% | 95.83% |
| CHEMBL236 | P41143 | Delta opioid receptor | 82.55% | 99.35% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 82.18% | 98.05% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 81.17% | 92.88% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 81.06% | 94.33% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 80.97% | 83.10% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 80.58% | 99.23% |
| CHEMBL2535 | P11166 | Glucose transporter | 80.40% | 98.75% |
| CHEMBL4835 | P00338 | L-lactate dehydrogenase A chain | 80.37% | 95.34% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 10819955 |
| LOTUS | LTS0017501 |
| wikiData | Q27149179 |